Literature DB >> 6309740

Genetic, molecular, and functional analysis of Streptococcus faecalis R plasmid pJH1.

M Banai, D J LeBlanc.   

Abstract

Streptococcus faecalis JH1 contains two conjugative plasmids, pJH1, an R plasmid that codes for resistance to kanamycin, streptomycin, erythromycin, and tetracycline, and pJH2, a hemolysin-bacteriocin plasmid. Strain JH1 was used as an antibiotic resistance donor in conjugation experiments with two plasmid-free S. faecalis recipient strains, JH2-2 and OG1-RF1. Plasmid pJH1 was purified from one transconjugant, DL77, and subjected to restriction endonuclease analyses. Five restriction enzymes, EcoRI, XbaI, BamHI, SalI, and XhoI, yielding 10, 9, 3, 2, and 2 fragments, respectively, were used to determine the size (80.7 kilobases) of pJH1 and to construct a restriction endonuclease map of the plasmid. Twenty-eight percent of the antibiotic-resistant transconjugants examined expressed only part of the resistance pattern (Kmr Smr Emr Tcr) associated with pJH1, that is, they were resistant to kanamycin, streptomycin, and erythromycin; to erythromycin and tetracycline; or to erythromycin or to tetracycline only. Most of these strains also produced hemolysin and bacteriocin, and several contained a hybrid plasmid consisting of pJH2 and specific segments of pJH1 DNA. Several of these hybrid plasmids, as well as a deletion derivative of pJH1 that coded for resistance to tetracycline but not to kanamycin, streptomycin, or erythromycin, were purified and used to confirm the arrangement of restriction endonuclease fragments on the pJH1 map and to locate the resistance determinants on this map.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6309740      PMCID: PMC217803          DOI: 10.1128/jb.155.3.1094-1104.1983

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  24 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Drug resistance in group D streptococci of clinical and nonclinical origin: prevalence, transferability, and plasmid properties.

Authors:  J D van Embden; H W Engel; B van Klingeren
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

3.  The gel electrophoresis of DNA.

Authors:  C Aaij; P Borst
Journal:  Biochim Biophys Acta       Date:  1972-05-10

4.  Plasmid-determined tetracycline resistance in Streptococcus faecalis: evidence for gene amplification during growth in presence of tetracycline.

Authors:  D B Clewell; Y Yagi; B Bauer
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

5.  Susceptibility of group D streptococcus (enterococcus) to 21 antibiotics in vitro, with special reference to species differences.

Authors:  P Toala; A McDonald; C Wilcox; M Finland
Journal:  Am J Med Sci       Date:  1969-12       Impact factor: 2.378

6.  Simple agarose gel electrophoretic method for the identification and characterization of plasmid deoxyribonucleic acid.

Authors:  J A Meyers; D Sanchez; L P Elwell; S Falkow
Journal:  J Bacteriol       Date:  1976-09       Impact factor: 3.490

7.  Transmissible toxin (hemolysin) plasmid in Streptococcus faecalis and its mobilization of a noninfectious drug resistance plasmid.

Authors:  G M Dunny; D B Clewell
Journal:  J Bacteriol       Date:  1975-11       Impact factor: 3.490

8.  Transferable plasmids mediating multiple-antibiotic resistance in Streptococcus faecalis subsp. liquefaciens.

Authors:  H P Marder; F H Kayser
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

9.  Conjugal transfer of plasmid-borne multiple antibiotic resistance in Streptococcus faecalis var. zymogenes.

Authors:  A E Jacob; S J Hobbs
Journal:  J Bacteriol       Date:  1974-02       Impact factor: 3.490

10.  Nucleotide sequence of the rightward operator of phage lambda.

Authors:  T Maniatis; A Jeffrey; D G Kleid
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

View more
  8 in total

1.  Diversity of the fsr-gelE region of the Enterococcus faecalis genome but conservation in strains with partial deletions of the fsr operon.

Authors:  Jessica R Galloway-Peña; Agathe Bourgogne; Xiang Qin; Barbara E Murray
Journal:  Appl Environ Microbiol       Date:  2010-11-19       Impact factor: 4.792

2.  Broad geographical distribution of homologous erythromycin, kanamycin, and streptomycin resistance determinants among group D streptococci of human and animal origin.

Authors:  D J LeBlanc; J M Inamine; L N Lee
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

3.  Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance.

Authors:  I Chopra; M Roberts
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

4.  Streptococcus faecalis R plasmid pJH1 contains an erythromycin resistance transposon (Tn3871) similar to transposon Tn917.

Authors:  M Banai; D J LeBlanc
Journal:  J Bacteriol       Date:  1984-06       Impact factor: 3.490

5.  Streptococcus faecalis R plasmid pJH1 contains a pAM alpha 1 delta 1-like replicon.

Authors:  M Banai; M A Gonda; J M Ranhand; D J LeBlanc
Journal:  J Bacteriol       Date:  1985-11       Impact factor: 3.490

6.  Genetic and pathogenic difference between Streptococcus agalactiae serotype Ia fish and human isolates.

Authors:  Chishih Chu; Pei-Yu Huang; Hung-Ming Chen; Ying-Hsiang Wang; I-An Tsai; Chih-Cheng Lu; Che-Chun Chen
Journal:  BMC Microbiol       Date:  2016-08-02       Impact factor: 3.605

7.  Genetic diversity among Enterococcus faecalis.

Authors:  Shonna M McBride; Vincent A Fischetti; Donald J Leblanc; Robert C Moellering; Michael S Gilmore
Journal:  PLoS One       Date:  2007-07-04       Impact factor: 3.240

8.  Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies.

Authors:  Carmen Giefing; Andreas L Meinke; Markus Hanner; Tamás Henics; Minh Duc Bui; Dieter Gelbmann; Urban Lundberg; Beatrice M Senn; Michael Schunn; Andre Habel; Birgitta Henriques-Normark; Ake Ortqvist; Mats Kalin; Alexander von Gabain; Eszter Nagy
Journal:  J Exp Med       Date:  2007-12-31       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.